Hormone drugs rebound after FDA removes warnings

Hormone replacement therapies are experiencing a significant resurgence in popularity following the FDA's decision to remove previous safety warnings. Women are actively seeking these treatments to alleviate menopausal symptoms such as hot flashes. This reversal in perception highlights a shift in medical understanding and patient acceptance of these drugs, which were once viewed with considerable caution. The increased demand underscores the unmet needs for effective symptom management during menopause.